Validity and reliability of the reflux symptom index (RSI)

Peter C. Belafsky, Gregory N Postma, James A. Koufman

Research output: Contribution to journalArticle

625 Citations (Scopus)

Abstract

Laryngopharyngeal reflux (LPR) is present in up to 50% of patients with voice disorders. Currently, there is no validated instrument that documents symptom severity in LPR. We developed the reflux symptom index (RSI), a self-administered nine-item outcomes instrument for LPR. The purpose of this investigation was to evaluate the psychometric properties of the RSI. For validity assessment, 25 patients with LPR were evaluated prospectively before and six months after b.i.d. treatment with proton pump inhibitors (PPI). Each patient completed the RSI as well as the 30-item voice handicap index (VHI). For reliability assessment, the study patients were given the RSI on two separate occasions before the initiation of treatment. Normative RSI data were derived from 25 age-matched and gender-matched controls taken from an existing database of asymptomatic individuals without any evidence of LPR. The mean RSI (± standard deviation) of patients with LPR improved from 21.2 (± 10.7) to 12.8 (± 10.0), and the mean VHI improved from 52.2 (± 24.7) to 41.5 (± 25.0) after 6 months of therapy (p = 0.001 and 0.065, respectively). Of the three VHI subscales (emotional, physical, functional), only the functional subscale improved significantly (p = 0.037). Patients who experienced a five point or better improvement in RSI were 11 times more likely to experience a five-point improvement in VHI (95% confidence interval = 1.7, 76.8). For reliability assessment, the first and second pretreatment RSIs were 19.9 (±11.1) and 20.9 (± 9.6), respectively (correlation coefficient = 0.81, p < 0.001). The single-item correlation coefficients ranged from 0.41 to 0.91 (p < 0.05 for all items). The mean pretreatment RSI in patients with LPR was significantly higher than controls (21.2 versus 11.6; p < 0.001). The mean RSI of patients with LPR after 6 months of PPI therapy approached that of asymptomatic controls (p > 0.05). The RSI is easily administered, highly reproducible, and exhibits excellent construct and criterion-based validity.

Original languageEnglish (US)
Pages (from-to)274-277
Number of pages4
JournalJournal of Voice
Volume16
Issue number2
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Laryngopharyngeal Reflux
Reproducibility of Results
Voice Disorders
Proton Pump Inhibitors
Psychometrics
Therapeutics
Databases
Confidence Intervals

Keywords

  • Gastroesophageal reflux
  • Laryngopharyngeal reflux
  • Outcome measures
  • Outcomes
  • Quality of life
  • Reflux
  • Symptoms

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Speech and Hearing
  • LPN and LVN

Cite this

Validity and reliability of the reflux symptom index (RSI). / Belafsky, Peter C.; Postma, Gregory N; Koufman, James A.

In: Journal of Voice, Vol. 16, No. 2, 01.01.2002, p. 274-277.

Research output: Contribution to journalArticle

Belafsky, Peter C. ; Postma, Gregory N ; Koufman, James A. / Validity and reliability of the reflux symptom index (RSI). In: Journal of Voice. 2002 ; Vol. 16, No. 2. pp. 274-277.
@article{7e8298ab10db4ed4bfedfcbebc76a4cd,
title = "Validity and reliability of the reflux symptom index (RSI)",
abstract = "Laryngopharyngeal reflux (LPR) is present in up to 50{\%} of patients with voice disorders. Currently, there is no validated instrument that documents symptom severity in LPR. We developed the reflux symptom index (RSI), a self-administered nine-item outcomes instrument for LPR. The purpose of this investigation was to evaluate the psychometric properties of the RSI. For validity assessment, 25 patients with LPR were evaluated prospectively before and six months after b.i.d. treatment with proton pump inhibitors (PPI). Each patient completed the RSI as well as the 30-item voice handicap index (VHI). For reliability assessment, the study patients were given the RSI on two separate occasions before the initiation of treatment. Normative RSI data were derived from 25 age-matched and gender-matched controls taken from an existing database of asymptomatic individuals without any evidence of LPR. The mean RSI (± standard deviation) of patients with LPR improved from 21.2 (± 10.7) to 12.8 (± 10.0), and the mean VHI improved from 52.2 (± 24.7) to 41.5 (± 25.0) after 6 months of therapy (p = 0.001 and 0.065, respectively). Of the three VHI subscales (emotional, physical, functional), only the functional subscale improved significantly (p = 0.037). Patients who experienced a five point or better improvement in RSI were 11 times more likely to experience a five-point improvement in VHI (95{\%} confidence interval = 1.7, 76.8). For reliability assessment, the first and second pretreatment RSIs were 19.9 (±11.1) and 20.9 (± 9.6), respectively (correlation coefficient = 0.81, p < 0.001). The single-item correlation coefficients ranged from 0.41 to 0.91 (p < 0.05 for all items). The mean pretreatment RSI in patients with LPR was significantly higher than controls (21.2 versus 11.6; p < 0.001). The mean RSI of patients with LPR after 6 months of PPI therapy approached that of asymptomatic controls (p > 0.05). The RSI is easily administered, highly reproducible, and exhibits excellent construct and criterion-based validity.",
keywords = "Gastroesophageal reflux, Laryngopharyngeal reflux, Outcome measures, Outcomes, Quality of life, Reflux, Symptoms",
author = "Belafsky, {Peter C.} and Postma, {Gregory N} and Koufman, {James A.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0892-1997(02)00097-8",
language = "English (US)",
volume = "16",
pages = "274--277",
journal = "Journal of Voice",
issn = "0892-1997",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Validity and reliability of the reflux symptom index (RSI)

AU - Belafsky, Peter C.

AU - Postma, Gregory N

AU - Koufman, James A.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Laryngopharyngeal reflux (LPR) is present in up to 50% of patients with voice disorders. Currently, there is no validated instrument that documents symptom severity in LPR. We developed the reflux symptom index (RSI), a self-administered nine-item outcomes instrument for LPR. The purpose of this investigation was to evaluate the psychometric properties of the RSI. For validity assessment, 25 patients with LPR were evaluated prospectively before and six months after b.i.d. treatment with proton pump inhibitors (PPI). Each patient completed the RSI as well as the 30-item voice handicap index (VHI). For reliability assessment, the study patients were given the RSI on two separate occasions before the initiation of treatment. Normative RSI data were derived from 25 age-matched and gender-matched controls taken from an existing database of asymptomatic individuals without any evidence of LPR. The mean RSI (± standard deviation) of patients with LPR improved from 21.2 (± 10.7) to 12.8 (± 10.0), and the mean VHI improved from 52.2 (± 24.7) to 41.5 (± 25.0) after 6 months of therapy (p = 0.001 and 0.065, respectively). Of the three VHI subscales (emotional, physical, functional), only the functional subscale improved significantly (p = 0.037). Patients who experienced a five point or better improvement in RSI were 11 times more likely to experience a five-point improvement in VHI (95% confidence interval = 1.7, 76.8). For reliability assessment, the first and second pretreatment RSIs were 19.9 (±11.1) and 20.9 (± 9.6), respectively (correlation coefficient = 0.81, p < 0.001). The single-item correlation coefficients ranged from 0.41 to 0.91 (p < 0.05 for all items). The mean pretreatment RSI in patients with LPR was significantly higher than controls (21.2 versus 11.6; p < 0.001). The mean RSI of patients with LPR after 6 months of PPI therapy approached that of asymptomatic controls (p > 0.05). The RSI is easily administered, highly reproducible, and exhibits excellent construct and criterion-based validity.

AB - Laryngopharyngeal reflux (LPR) is present in up to 50% of patients with voice disorders. Currently, there is no validated instrument that documents symptom severity in LPR. We developed the reflux symptom index (RSI), a self-administered nine-item outcomes instrument for LPR. The purpose of this investigation was to evaluate the psychometric properties of the RSI. For validity assessment, 25 patients with LPR were evaluated prospectively before and six months after b.i.d. treatment with proton pump inhibitors (PPI). Each patient completed the RSI as well as the 30-item voice handicap index (VHI). For reliability assessment, the study patients were given the RSI on two separate occasions before the initiation of treatment. Normative RSI data were derived from 25 age-matched and gender-matched controls taken from an existing database of asymptomatic individuals without any evidence of LPR. The mean RSI (± standard deviation) of patients with LPR improved from 21.2 (± 10.7) to 12.8 (± 10.0), and the mean VHI improved from 52.2 (± 24.7) to 41.5 (± 25.0) after 6 months of therapy (p = 0.001 and 0.065, respectively). Of the three VHI subscales (emotional, physical, functional), only the functional subscale improved significantly (p = 0.037). Patients who experienced a five point or better improvement in RSI were 11 times more likely to experience a five-point improvement in VHI (95% confidence interval = 1.7, 76.8). For reliability assessment, the first and second pretreatment RSIs were 19.9 (±11.1) and 20.9 (± 9.6), respectively (correlation coefficient = 0.81, p < 0.001). The single-item correlation coefficients ranged from 0.41 to 0.91 (p < 0.05 for all items). The mean pretreatment RSI in patients with LPR was significantly higher than controls (21.2 versus 11.6; p < 0.001). The mean RSI of patients with LPR after 6 months of PPI therapy approached that of asymptomatic controls (p > 0.05). The RSI is easily administered, highly reproducible, and exhibits excellent construct and criterion-based validity.

KW - Gastroesophageal reflux

KW - Laryngopharyngeal reflux

KW - Outcome measures

KW - Outcomes

KW - Quality of life

KW - Reflux

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=0036594395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036594395&partnerID=8YFLogxK

U2 - 10.1016/S0892-1997(02)00097-8

DO - 10.1016/S0892-1997(02)00097-8

M3 - Article

VL - 16

SP - 274

EP - 277

JO - Journal of Voice

JF - Journal of Voice

SN - 0892-1997

IS - 2

ER -